Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway

Abstract

Agonistic antibodies against the Fas receptor, when administered to mice in vivo, cause significant apoptosis in the liver. In this study we show that anti-Fas antibody not only causes apoptosis of liver cells but also provokes hepatic inflammation. Two hours after injection of antiFas, when mice displayed evidence of caspase-3 activation and apoptosis, we found significant hepatic induction of the CXC chemokines macrophage inflammatory protein-2 and KC. Coincident with the chemokine induction was infiltration of the hepatic parenchyma by neutrophils. Neutralization experiments identified that chemokines were the cause of Fas-induced hepatic inflammation, with KC having the predominant effect. Chemokine induction in the livers of anti-Fas-treated mice was not associated with activation of NF-B. Instead, it coincided with nuclear translocation of activator protein-1 (AP-1). AP-1 activation in liver was detected 1-2 h after anti-Fas treatment, suggesting a connection to the onset of apoptosis. When apoptosis was prevented by pretreating mice with a caspase-3 inhibitor, AP-1 activation and hepatic chemokine production were both significantly reduced. Hepatic inflammation was also reduced by 70%. Taken together, these findings indicate that Fas ligation can induce inflammation in the liver in vivo. Inflammation does not arise from Fas-mediated signaling through NF-B; rather, it represents an indirect effect, requiring activation of caspase-3 and nuclear translocation of AP-1.

How dying cells alert the immune system to danger

“…This model can explain why live cells, which contain preexisting danger signals, don't stimulate the innate immune system. Moreover, it can also explain why necrotic cells always stimulate the innate immune system, whereas apoptotic cells are only stimulatory in some situations 92 but not others 93 . This is because necrotic cells always lose membrane permeability and release their intracellular contents.…”

Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman Symposium

“…14 Increased apoptosis of hepatocytes results in increased fibrosis in experimental models. 15 Hepatocyte apoptosis produces chemokines and inflammation, 16 which in turn may activate HSCs. Furthermore, apoptosis of hepatocytes results in generation of apoptotic bodies, which can release lipid signals for their uptake by Kupffer cells and HSCs.…”

“…Genome and proteome expression and whole genome single nucleotide polymorphism (SNP) scans studies in livers from a large number of patients with alcoholic liver fibrosis 15. Characterization of key genes initiating apoptosis of activated HSCs during the resolution of fibrosis 16. Identification of agents that will selectively kill activated HSCs via inducing apoptosis or necrosis 17.…”

Novel Role for Amphiregulin in Protection from Liver Injury

“…More recently hepatocyte apoptosis has been reported to occur in the liver of patients with nonalcoholic steatohepatitis, correlating with the severity of the disease (4). The consequences of hepatocellular apoptosis may extend beyond the mere loss of functional liver mass, because moderate and persistent apoptosis may contribute to the development of liver inflammation and fibrosis (5,6). Apoptosis can be triggered by the activation of two molecular pathways: an intrinsic mitochondrially mediated cascade and a death receptor pathway.…”